Gender | |
Male | 11 (45.83%) |
Female | 13 (54.16%) |
Age | |
Children (1–17 years) | 21 (87.5%) |
Adult (18 years and above) | 3 (12.5%) |
History of malaria and treatment taken | |
History of treatment before reporting to study hospital | 11 (45.83%) |
History of malaria in last 6 months | 2 (8.33%) |
Clinical findings | |
Palpable splenomegaly | 10 (41.66%) |
Palpable hepatomegaly | 11 (45.83%) |
Malaria diagnosis | |
Positive by microscopy | 10 (41.7%) |
Positive by both microscopy RDT | 9 (37.5%) |
Positive by RDT | 5 (20.8%) |
Hemoglobin level | |
Range of Hb level on day 0 | 4.9–13.1 g/dl |
Severe malaria criteria on day 0 | |
Severe anemia | 8 (33.33%) |
Impaired consciousness | 8 (33.33%) |
Respiratory distress- SPO2 < 92% on room air with any signs of respiratory rate > 30/min or presence of crepitations on auscultation | 6 (25%) |
Hyperparasitemia | 4(16.66%) |
Jaundice- plasma or serum Bilirubin > 3 mg/dl | 3 (12.5%) |
Shock with systolic blood pressure < 70 mm Hg in children and < 80 mm Hg in adults | 2 (8.33%) |
Multiple convulsions | 1 (4.16%) |
Renal impairment—plasma or serum creatinine > 3 mg/dl | 1 (4.16%) |
Prostration | 1(4.16%) |